2026 / 04

DOI: 10.24075/brsmu.2026.043
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Molecular genetic aspects of predicting early pregnancy loss

Yusef OV1 , Ibragimov BR2 , Klimenko MP1 , Gerasimova AA3 , Aimetdinova AB1 , Marnat EG1 , Abramov DD4 , Klimenko PA1 , Kurtser MA1
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Dagestan State Medical University, Makhachkala, Russia

3 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia

4 Institute of Immunology of the Federal Medical Biological Agency of Russia, Moscow, Russia

Correspondence should be addressed: Pyotr A. Klimenko
Sevastopolsky prospekt, 24а, Moscow, 117209; ur.liam@oknemilk.ap

About paper

Funding: the study was conducted as part of the Program for Basic Research in the Russian Federation for the Long Term (2021–2030) (No. 122030100170-5).

Author contribution: Yusef OV — clinical material collection, laboratory testing; Ibragimov BR — statistical processing, analysis of results; Klimenko MP — database creation; Gerasimova AA — ultrasound examination, clinical assessment of results; Aimetdinova AB — clinical and functional assessment of patients; Marnat EG — laboratory testing (PCR); Abramov DD — literature review, interpretation of results, manuscript writing; Klimenko PA — study design, clinical phase arrangement, interpretation of results; Kurtser MA — study concept and design, academic advising, manuscript approval.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Pirogov Russian National Research Medical University (protocol No. 258 dated February 16, 2026). All the surveyed individuals submitted the informed consent to take part in the study.

Received: 2026-06-24 Accepted: 2026-08-05 Published online: 2026-08-18
|
  1. Malinovskaya EM, Ershova ES, Golimbet VE, Porokhovnik LN, Lyapunova NA, Kutsev SI, et al. Copy Number of Human Ribosomal Genes With Aging: Unchanged Mean, but Narrowed Range and Decreased Variance in Elderly Group. Front Genet. 2018; 9: 306. DOI: 10.3389/fgene.2018.00306. PMID: 30131826; PMCID: PMC6090032.
  2. Lyapunova NA, Vejko NN. Ribosomnye geny v genome cheloveka: identifikaciya chetyrekh frakcij, ih lokalizaciya v yadryshke i metafaznyh hromosomah. Genetika. 2010; 46 (9): 1205–9. Russian.
  3. Myao Z, Chen M, U H, Din H, Shi Z. Sravnitel'nyj proteomnyj profil' chelovecheskoj placenty v normal'nom i fetal'nom roste Restrikcionnye sub"ekty. Cell Physiol Biochem. 2014; 34: 1701–10.
  4. Tubaon R, Haddad P, Kirino Dzh. Strategii ochistki obrazcov dlya prilozhenij mass-spektrometrii ESI v voskhodyashchej proteomike: Tendencii s 2012 po 2016 god. Proteomika. 2017; 17: 1700011.
  5. Horami Sarvestani S, Shodzhaeyan S, Vanaki N, Gresi-Fard B, Amini M, Dzhilani K, i dr. Proteomnoe profilirovanie chelovecheskoj placenty vyyavlyaet izmeneniya v belkovoj signature, zavisyashchie ot stadii razvitiya. Klinicheskaya proteomika. 2021; 18: 18.
  6. Braunridzh P, Bejnon R. Vazhnost' dajdzhesta: proteoliz i absolyutnaya kolichestvennaya ocenka v proteomike. Metody. 2011; 54: 351–60.
  7. Matthielsen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol. 2012; 67 (4): 334–40.
  8. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and −9) in human trophoblast invasion. Reprod Biol Endocrinol. 2004; 2: 59.
  9. Moore CS, Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol. 2012; 180: 12–16.
  10. Kizaki K, Ushizawa K, Takahashi T, Yamada O, Todoroki J, Sato T, et al. Gelatinase (MMP-2 and −9) expression profiles during gestation in the bovine endometrium. Reprod Biol Endocrinol. 2008; 6: 66.
  11. Seval Y, Akkoyunlu G, Demir R, Asar M. Distribution pattern of matrix metalloproteinase MMP-2 and MMP-9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem. 2004; 5: 353–62.
  12. Diaz P, Solar P, Juica N, Orihuela P, Cardenas H, Christodoulides M, et al. Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle. Reprod Biol Endocrinol. 2012; 10: 56.
  13. Zaga-Clavellina V, Garcia-Lopez G, Flores-Pliego A, MerchantLarios H, Vadillo-Ortega F. In vitro secretion and activity profiles of matrix metalloproteinases MMP-9 and MMP-2 in human term extra-placental membranes after exposure to Escherichia coli. Reprod Biol Endocrinol. 2011; 9: 13–15.
  14. Yusefzade J, Soltani-Zangbar MS, Hemmatzade M, Shomali N, Mahmudpur A, Heris DzhA, et al. Fetomaterinskaya immunnaya tolerantnost': vazhnejshie mekhanizmy tolerantnosti dlya uspeshnoj beremennosti u cheloveka. Immunolog. issledovaniya. 2022; 51: 1108–25.
  15. Munos-Suano A, Gamilton AB, Betc AG. Dajte mne ubezhishche: immunnaya sistema vo vremya beremennosti. Immunologicheskij obzor. 2011; 241: 20–38.
  16. Parhizkar F, Motavalli-Hiavi R, Agebati-Maleki L, Parhizkar Purakbari, Kafil HS, i dr. Vliyanie novyh immunologicheskih terapevticheskih strategij na recidiviruyushchie vykidyshi i recidiviruyushchie neudachi implantacii. Immunologiya. Pis'ma. 2021; 236: 20–30.
  17. Parhizkar F, Kiani A, Darzi S, Motavalli R, Dolama FN, Yusefzade Yu, i dr. Ocenka ekspressii CD39, CD73 i HIF-1α, a takzhe rodstvennyh im mikroRNK v RVMS zhenshchin s privychnym nevynashivaniem beremennosti. Dzh Reprod Immunol. 2023; 156: 103820.
  18. Nin F, Lyu H, Lash GE. Rol' decidual'nyh makrofagov vo vremya normal'noj i patologicheskoj beremennosti. Am J Reprod Immunol. 2016; 75: 298–309.
  19. Yutel M, Akdis M, Budak F, Ebisher-Kasaulta K, Vzhishch M, Blazer K, i dr. IL-10 i TGF-beta vzaimodejstvuyut v otvete regulyatornyh T-kletok na slizistye allergeny pri normal'nom immunitete i specificheskoj immunoterapii. Eur J Immunol. 2003; 33: 1205–14.
  20. Herder K, Zirer A, Kenig V, Roden M, Mejzinger K, Torand B. Transformiruyushchij faktor rosta β1 i vozniknovenie diabeta 2 tipa: rezul'taty kogortnogo issledovaniya MONICA/KORA, 1984– 2002 gg. Diabetes Care. 2009; 32: 1921–23.
  21. Chzhu Dzh, Song G, Chzhou S, Han T-L, Y S, Chen H, i dr. Narushenie regulyacii metabolizma adenozina CD39/CD73 uvelichivaet citotoksichnost' decidual'nyh estestvennyh kletokkillerov: posledstviya dlya neob"yasnimyh recidiviruyushchih samoproizvol'nyh abortov. Front Immunol. 2022; 13: 813218.
  22. Allan DSDzh, Rybalov B, Avong G, Zuniga-Pflyuker DzhK, Kopkov HD, Karlajl DzhR, dr. TGF-β vliyaet na razvitie i differencirovku subpopulyacij estestvennyh kletok-killerov cheloveka. Eur J Immunol. 2010; 40: 2289–95.
  23. Shalmin F, Mino G, Brushar M, Shevrio A, Vegran F, Ishami A, i dr. Transkripcionnye faktory Stat3 i Gfi-1 kontroliruyut immunosupressivnuyu aktivnost' Th17-kletok posredstvom regulyacii ekspressii ektonukleotidazy. Immunitet. 2012; 36: 362–73.
  24. Shuler P Dzh, Shilling B, Harasimchuk M, Hoffmann TK, Dzhonson Dzh, Lang S, Uajtsajd TL. Fenotipicheskie i funkcional'nye harakteristiki subpopulyacij T-kletok CD4+ CD39+ FOXP3+ i CD4+ CD39+ FOXP3neg u onkologicheskih bol'nyh. Eur J Immunol. 2012; 42: 1876–85.
  25. Eltcshig HK, Sitkovski MV, Robson SK. Purinergicheskaya signalizaciya vo vremya vospaleniya. N Engl J Med. 2012; 367: 2322–33.